Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

209.05
+0.10000.05%
Post-market: 209.800.7500+0.36%19:56 EDT
Volume:1.22M
Turnover:254.37M
Market Cap:10.53B
PE:33.12
High:209.84
Open:207.24
Low:206.01
Close:208.95
52wk High:217.12
52wk Low:138.79
Shares:50.35M
Float Shares:50.35M
Volume Ratio:0.90
T/O Rate:2.43%
Dividend:0.42
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.29
PE(LYR):-139.93

Loading ...

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Sector Update: Healthcare

MT Newswires Live
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Political and General News Events from August 28

Reuters
·
Aug 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Reuters
·
Aug 28

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Reuters
·
Aug 28

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

TIPRANKS
·
Aug 28

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

Reuters
·
Aug 28

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS
·
Aug 28

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Dow Jones
·
Aug 28

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Aug 28

Sector Update: Healthcare

MT Newswires Live
·
Aug 28

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

TIPRANKS
·
Aug 28

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

TIPRANKS
·
Aug 27

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Reuters
·
Aug 27